Venom of the ant Pseudomyrmex sp.

Further characterization of two factors that affect human complement proteins

D. R. Schultz, P. I. Arnold

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Two factors in the venom of the tropical ant Pseudomyrmex sp. had potent anti-complementary activity. The first (F1) was resistant to boiling and had the properties of a polysaccharide or glycoprotein. It had no effect on purified C4 and C2, but caused activation of C1, resulting in the consumption of C4 and C2 in normal human serum. F1 appeared to activate C1 by forming a complex with a nonimmunoglobulin factor in normal human serum. The serum factor was not C1q. The second venom factor (F2) was heatlabile (56°C, 30 min), and was identified as a trypsin-like enzyme. It hydrolyzed α-N-benzoyl-DL-arginine p-nitroanilide HCl and was inhibited by soybean trypsin inhibitor, but not by EDTA. It caused inactivation of purified complement components, but not components in serum, presumably because of natural serum inhibitors. F1 and F2 were closely associated in native ant venom. After gel filtration of the venom, two complement inactivators were eluted. They had m.w. of 175,000 and 32,500 daltons, but F1 and F2 were associated with both m.w. species. F1 and F2 migrated together after electrophoresis on polyacrylamide gels, and both were identified in the ultrafiltrate of ultrafiltration membranes having an m.w. cut-off of 10,000 daltons. The results of this report and previous studies show that ant venom is a potent activator/inactivator of components in both the classical and alternative complement pathways.

Original languageEnglish
Pages (from-to)1690-1699
Number of pages10
JournalJournal of Immunology
Volume119
Issue number5
StatePublished - Dec 1 1977
Externally publishedYes

Fingerprint

Ant Venoms
Complement System Proteins
Serum
Venoms
Classical Complement Pathway
Alternative Complement Pathway
Trypsin Inhibitors
Ultrafiltration
Soybeans
Edetic Acid
Trypsin
Gel Chromatography
Polysaccharides
Arginine
Polyacrylamide Gel Electrophoresis
Glycoproteins
Membranes
Enzymes

ASJC Scopus subject areas

  • Immunology

Cite this

Venom of the ant Pseudomyrmex sp. Further characterization of two factors that affect human complement proteins. / Schultz, D. R.; Arnold, P. I.

In: Journal of Immunology, Vol. 119, No. 5, 01.12.1977, p. 1690-1699.

Research output: Contribution to journalArticle

@article{0b672327fd85435cbcc4bd32130d0d56,
title = "Venom of the ant Pseudomyrmex sp.: Further characterization of two factors that affect human complement proteins",
abstract = "Two factors in the venom of the tropical ant Pseudomyrmex sp. had potent anti-complementary activity. The first (F1) was resistant to boiling and had the properties of a polysaccharide or glycoprotein. It had no effect on purified C4 and C2, but caused activation of C1, resulting in the consumption of C4 and C2 in normal human serum. F1 appeared to activate C1 by forming a complex with a nonimmunoglobulin factor in normal human serum. The serum factor was not C1q. The second venom factor (F2) was heatlabile (56°C, 30 min), and was identified as a trypsin-like enzyme. It hydrolyzed α-N-benzoyl-DL-arginine p-nitroanilide HCl and was inhibited by soybean trypsin inhibitor, but not by EDTA. It caused inactivation of purified complement components, but not components in serum, presumably because of natural serum inhibitors. F1 and F2 were closely associated in native ant venom. After gel filtration of the venom, two complement inactivators were eluted. They had m.w. of 175,000 and 32,500 daltons, but F1 and F2 were associated with both m.w. species. F1 and F2 migrated together after electrophoresis on polyacrylamide gels, and both were identified in the ultrafiltrate of ultrafiltration membranes having an m.w. cut-off of 10,000 daltons. The results of this report and previous studies show that ant venom is a potent activator/inactivator of components in both the classical and alternative complement pathways.",
author = "Schultz, {D. R.} and Arnold, {P. I.}",
year = "1977",
month = "12",
day = "1",
language = "English",
volume = "119",
pages = "1690--1699",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - Venom of the ant Pseudomyrmex sp.

T2 - Further characterization of two factors that affect human complement proteins

AU - Schultz, D. R.

AU - Arnold, P. I.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - Two factors in the venom of the tropical ant Pseudomyrmex sp. had potent anti-complementary activity. The first (F1) was resistant to boiling and had the properties of a polysaccharide or glycoprotein. It had no effect on purified C4 and C2, but caused activation of C1, resulting in the consumption of C4 and C2 in normal human serum. F1 appeared to activate C1 by forming a complex with a nonimmunoglobulin factor in normal human serum. The serum factor was not C1q. The second venom factor (F2) was heatlabile (56°C, 30 min), and was identified as a trypsin-like enzyme. It hydrolyzed α-N-benzoyl-DL-arginine p-nitroanilide HCl and was inhibited by soybean trypsin inhibitor, but not by EDTA. It caused inactivation of purified complement components, but not components in serum, presumably because of natural serum inhibitors. F1 and F2 were closely associated in native ant venom. After gel filtration of the venom, two complement inactivators were eluted. They had m.w. of 175,000 and 32,500 daltons, but F1 and F2 were associated with both m.w. species. F1 and F2 migrated together after electrophoresis on polyacrylamide gels, and both were identified in the ultrafiltrate of ultrafiltration membranes having an m.w. cut-off of 10,000 daltons. The results of this report and previous studies show that ant venom is a potent activator/inactivator of components in both the classical and alternative complement pathways.

AB - Two factors in the venom of the tropical ant Pseudomyrmex sp. had potent anti-complementary activity. The first (F1) was resistant to boiling and had the properties of a polysaccharide or glycoprotein. It had no effect on purified C4 and C2, but caused activation of C1, resulting in the consumption of C4 and C2 in normal human serum. F1 appeared to activate C1 by forming a complex with a nonimmunoglobulin factor in normal human serum. The serum factor was not C1q. The second venom factor (F2) was heatlabile (56°C, 30 min), and was identified as a trypsin-like enzyme. It hydrolyzed α-N-benzoyl-DL-arginine p-nitroanilide HCl and was inhibited by soybean trypsin inhibitor, but not by EDTA. It caused inactivation of purified complement components, but not components in serum, presumably because of natural serum inhibitors. F1 and F2 were closely associated in native ant venom. After gel filtration of the venom, two complement inactivators were eluted. They had m.w. of 175,000 and 32,500 daltons, but F1 and F2 were associated with both m.w. species. F1 and F2 migrated together after electrophoresis on polyacrylamide gels, and both were identified in the ultrafiltrate of ultrafiltration membranes having an m.w. cut-off of 10,000 daltons. The results of this report and previous studies show that ant venom is a potent activator/inactivator of components in both the classical and alternative complement pathways.

UR - http://www.scopus.com/inward/record.url?scp=0017724607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017724607&partnerID=8YFLogxK

M3 - Article

VL - 119

SP - 1690

EP - 1699

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -